lattice radiation therapy

RADIATION3 trials

Sponsors

Azienda USL Reggio Emilia - IRCCS, Tianjin Medical University Cancer Institute and Hospital

Conditions

CancerImmune Checkpoint InhibitorImmune Checkpoint InhibitorsLocally Advanced Non-small Cell Lung Cancer (NSCLC)Lung CancerNeoadjuvant ChemoimmunotherapyPalliative RadiotherapyRadiotherapy

Phase 2

LAttice Radiation Therapy for Large Lesions: Reggio Emilia Single-arm Phase II Trial

RecruitingNCT07000162

Azienda USL Reggio Emilia - IRCCSCancer, Palliative Radiotherapy

Start: 2025-05-26End: 2028-05-01Target: 56Updated: 2025-08-29

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

RecruitingNCT07058948

Tianjin Medical University Cancer Institute and HospitalImmune Checkpoint Inhibitor, Lung Cancer, Radiotherapy +1

Start: 2025-07-01End: 2027-07-01Target: 30Updated: 2026-04-29

Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response

Not yet recruitingNCT07670715

Tianjin Medical University Cancer Institute and HospitalImmune Checkpoint Inhibitors, Locally Advanced Non-small Cell Lung Cancer (NSCLC), Neoadjuvant Chemoimmunotherapy +1

Start: 2026-07-01End: 2028-07-01Target: 30Updated: 2026-06-26